Fridays vs Remi Meds
Fridays and Remi Meds both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
If you are choosing between Fridays and Remi Meds, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. They tie at 5.7 on our six-part score.
Fridays vs Remi Meds price
Fridays and Remi Meds start at the same figure, $249 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $249 a month; tirzepatide is cheaper at Remi Meds ($349 a month vs $359 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Fridays prices compounded injections and brand-name pens, while Remi Meds prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Fridays is the only one of the two with a brand-name price.
Where each one treats patients
Neither Fridays nor Remi Meds publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Fridays
Remi Meds
What each price covers
Both prices cover the medication itself.
Fridays' price also covers the clinician visit and coaching, which Remi Meds does not claim.
Fridays is silent on shipping and lab work.
Remi Meds is silent on the clinician visit, shipping, lab work and coaching.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Remi Meds
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall they tie at 5.7 out of 10.
Fridays is stronger on value (2.9 vs 0.0) and support (7.0 vs 5.0).
Remi Meds is stronger on user experience (8.0 vs 3.0) and trust & safety (6.5 vs 5.5).
Effectiveness and accessibility are within half a point.
Fridays
5.7/10
Remi Meds
5.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor Remi Meds has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Remi Meds |
|---|---|---|
| Starting Price | $249/mo | $249/mo |
| Features | 2 features | ✓7 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Remi Meds
Every dose tier carries a published price instead of a floor-only 'as low as' figure: semaglutide $249-$369/mo, tirzepatide $349-$639/mo. Remi Meds is a DTC platform selling compounded semaglutide and tirzepatide-with-B12 by tier, with Glutathione, Sermorelin and NAD+ sold as add-ons. Both its clinical network, Beluga Health, and its pharmacy partner, Strive Pharmacy of Gilbert, AZ, are named. Remedy Meds is a separate company.
Read our full Remi Meds review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Remi Meds
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- We found no FDA warning letters issued to Remi Meds
Watch-outs
- Semaglutide costs $369 a month, 99% above the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $639 a month, 156% above the $250 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Fridays and Remi Meds finish level at 5.7. Choose on the state list and on what each monthly price covers.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Remi Meds if…
You want compounded semaglutide at $369/month and an opening price near $249 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Fridays vs Remi Meds: FAQ
Close alternatives to Fridays and Remi Meds
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Remi Meds vs Henry Meds
- Remi Meds vs Direct Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.